Sweden's Wallenberg Group has partnered with AstraZeneca, Ericsson, Saab, and SEB to form a new AI company focused on developing advanced infrastructure for Swedish industry and research. This strategic consortium unites expertise from pharmaceuticals, technology, defense, finance, and investment sectors to enhance Sweden's global AI competitiveness. The initiative will develop secure, ethical AI systems, foster academia-industry collaboration, and address growing demands for computational resources needed by modern AI technologies. The venture complements the existing Wallenberg AI research program (WASP) and demonstrates Sweden's commitment to becoming a leader in responsible AI development and application.